INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 59 filers reported holding INSTIL BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,706 | -22.3% | 251,650 | 0.0% | 0.00% | – |
Q2 2023 | $138,659 | -84.3% | 251,650 | -81.1% | 0.00% | – |
Q1 2023 | $880,959 | -45.9% | 1,333,170 | -48.4% | 0.00% | – |
Q4 2022 | $1,627,558 | -70.0% | 2,583,424 | +130.7% | 0.00% | – |
Q3 2022 | $5,420,000 | +26.8% | 1,119,932 | +21.0% | 0.00% | – |
Q2 2022 | $4,276,000 | -53.5% | 925,526 | +8.2% | 0.00% | – |
Q1 2022 | $9,194,000 | -29.4% | 855,254 | +12.3% | 0.00% | -100.0% |
Q4 2021 | $13,030,000 | +148.9% | 761,572 | +160.0% | 0.00% | – |
Q3 2021 | $5,235,000 | +8.4% | 292,893 | +17.1% | 0.00% | – |
Q2 2021 | $4,831,000 | – | 250,061 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |